<?xml version="1.0" encoding="UTF-8"?>
<p>Practical or feasibility considerations may justify use of a high-risk group, for example, if there is a risk of obtaining an inconclusive result in a nontargeted trial, if the available supply of vaccine is limited so a smaller trial is necessary, or if there are substantial resource savings from conducting the study in a high-risk group.</p>
